Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

RMD stock hub

ResMed Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

RMDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

30B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

RMD

In the news

Latest news · RMD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.3

P25 12.3P50 18.4P75 33.1

Trailing P/E19.9

P25 14.9P50 23.2P75 38.5

ROE25.2

P25 -105.6P50 -46.5P75 -3.1

ROIC26.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All RMD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

282

Groups with data

Currency

USD

Showing 282 of 282 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000943819
Company name	ResMed Inc.
Country	United States
Country code	US
Cusip	761152107
Employees	9,980
Employees Change	-160%
Employees Change Percent	-1.58
Enterprise value	$29.2B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Medical Instruments & Supplies
IPO Date	1995-06-02
Isin	US7611521078
Last refreshed	2026-05-10
Market cap	$30B
Market cap category	Large-Cap
Price	$207
Price currency	USD
Rev Per Employee	554,888.68x
Sector	Healthcare
Sic	3841
Symbol	RMD
Website	https://www.resmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.07%
EV Earnings	19.2x
EV Sales Forward	9.97x
EV/EBIT	15.16x
EV/EBITDA	13.76x
EV/FCF	16.63x
EV/Sales	5.27x
FCF yield	5.85%
Forward P/E	17.33x
P/B ratio	4.62x
P/E ratio	19.94x
P/S ratio	5.42x
PE Ratio10 Y	38.74x
PE Ratio3 Y	27.5x
PE Ratio5 Y	37.8x
PEG ratio	1.23x
PS Forward	10.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.76%
EBITDA Margin	38.27%
FCF margin	31.68%
Gross margin	62.18%
Gross Profit	$3.4B
Gross Profit Growth	15.51%
Gross Profit Growth Q	16.15%
Gross Profit Growth3 Y	14.58%
Gross Profit Growth5 Y	13.24%
Net Income	$1.5B
Net Income Growth	15.71%
Net Income Growth Q	9.23%
Net Income Growth Quarters	9%
Net Income Growth Years	4%
Net Income Growth3 Y	20.76%
Net Income Growth5 Y	27.15%
Pretax Margin	34.37%
Profit Margin	27.44%
Profit Per Employee	$152,261
Profitable Years	32
ROA	14.72
Roa5y	12.79
ROCE	25.9
ROE	25.25
Roe5y	23.02
ROIC	26.9
Roic5y	20.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	15.17%
Cagr15y	14.6%
Cagr1y	-14.76%
Cagr20y	12.38%
Cagr3y	-2.81%
Cagr5y	2.04%
Div CAGR10	7.18%
Div CAGR3	10.89%
Div CAGR5	9%
EPS Growth	16.39
EPS Growth Q	10.48
EPS Growth Quarters	9
EPS Growth Years	4
EPS Growth3 Y	20.96
EPS Growth5 Y	27.08
FCF Growth	11.82%
FCF Growth Q	-6.7%
FCF Growth3 Y	60.86%
FCF Growth5 Y	18.6%
OCF Growth	14.34%
OCF Growth Q	-4.24%
OCF Growth10 Y	14.12%
OCF Growth3 Y	52.27%
OCF Growth5 Y	17.59%
Revenue Growth	10.28x
Revenue Growth Q	10.81x
Revenue Growth Quarters	20x
Revenue Growth Years	31x
Revenue Growth3 Y	11.31x
Revenue Growth5 Y	12.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.68
Assets	$8.8B
Cash	$1.7B
Current Assets	$4.1B
Current Liabilities	$1.4B
Debt	$843.2M
Debt EBITDA	$0.39
Debt Equity	$0.13
Debt FCF	$0.48
Equity	$6.5B
Liabilities	$2.3B
Long Term Assets	$4.7B
Long Term Liabilities	$941.2M
Net Cash	$817.3M
Net Cash By Market Cap	$2.73
Net Cash Growth	779.44%
Net Debt EBITDA	$-0.39
Net Debt Equity	$-0.13
Net Debt FCF	$-0.47
Tangible Book Value	$3B
Tangible Book Value Per Share	$20.85
WACC	8.65

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.01
Inventory Turnover	2.24
Net Working Capital	$1.3B
Quick ratio	2
Working Capital	$2.7B
Working Capital Turnover	$2.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.62%
Dividend Growth	13.21%
Dividend Growth Years	14%
Dividend per share	$2.4
Dividend Years	15
Dividend Yield	1.16%
Ex Div Date	2026-05-14
Last Dividend	$0.6
Payout Frequency	Quarterly
Payout Ratio	23.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	310.6%
1Y total return	-14.75%
200-day SMA	254.4
3Y total return	-8.19%
50-day SMA	228.1
50-day SMA vs 200-day SMA	50under200
5Y total return	10.61%
All Time High	301.3
All Time High Change	-31.39%
All Time High Date	2021-09-09
All Time Low	0.61
All Time Low Change	33,828.45%
All Time Low Date	1995-06-07
ATR	5.82
Beta	0.84
Beta1y	0.58
Beta2y	0.66
Ch YTD	-14.16
High	208
High52	293.8
High52 Date	2025-08-22
High52ch	-29.63%
Low	203.9
Low52	198.6
Low52 Date	2026-05-01
Low52ch	4.09%
Ma50ch	-9.36%
Price vs 200-day SMA	-18.71%
RSI	33.08
RSI Monthly	41.97
RSI Weekly	32.02
Sharpe ratio	-0.8x
Sortino ratio	-0.81
Total Return	1.78%
Tr YTD	-13.96
Tr15y	672.07%
Tr1m	-8.53%
Tr1w	0.85%
Tr3m	-23.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	2
Analyst Price Target Top	$285
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$2.8
Earnings EPS Estimate Growth	18.14
Earnings Revenue Estimate	1,421,536,288x
Earnings Revenue Estimate Growth	10.03x
Operating Income	$1.9B
Operating Income Growth	19.41
Operating Income Growth Q	18.63
Operating Income Growth3 Y	19.68
Operating Income Growth5 Y	16.44
Operating margin	34.76
Price target	$289
Price Target Change	$39.56
Price Target Change Top	$37.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	144,169,809%
Float Percent	99.39%
Net Borrowing	-10,000,000
Shares Insiders	0.52%
Shares Institutions	76.08%
Shares Out	145,056,384
Shares Qo Q	-0.44%
Shares Yo Y	-0.62%
Short Float	7.97%
Short Ratio	11.56
Short Shares	7.92

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$1.7B
Average Volume	1,344,008.25x
Bv Per Share	44.76
CAPEX	$-135.7M
Ch10y	266.1
Ch15y	540.1
Ch1m	-8.53
Ch1w	0.85
Ch1y	-15.5
Ch20y	755.1
Ch3m	-23.88
Ch3y	-10.74
Ch5y	5.94
Ch6m	-17.79
Change	-0.06%
Change From Open	-0.01
Close	206.9
Days Gap	-0.05
Depreciation Amortization	194,624,000
Dollar Volume	205,410,684.2
Earnings Date	2026-04-30
Earnings Time	amc
EBIT	$1.9B
EBITDA	$2.1B
EPS	$10.37
F Score	6
FCF	$1.8B
FCF EV Yield	6.01x
FCF Per Share	$12.09
Financing CF	-907,752,000
Fiscal Year End	June
Founded	1,989
Goodwill	3,043,136,000
Graham Number	102.19557
Graham Upside	-50.57
Income Tax	$383.7M
Investing CF	-295,261,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Date	2010-08-31
Last Split Type	Forward
Last10k Filing Date	2025-08-08
Lynch Fair Value	$259
Lynch Upside	25.39
Ma150	246.5
Ma150ch	-16.11%
Ma20	218.1
Ma20ch	-5.2%
Net CF	727,802,000
Next Earnings Date	2026-07-30
Open	206.8
Optionable	Yes
P FCF Ratio	17.1
P OCF Ratio	15.87
Payment Date	2026-06-18
Position In Range	69.95
Post Close	206.8
Postmarket Change Percent	-0.37
Postmarket Price	$206
Ppne	728,574,000
Price Date	2026-05-08
Price EBITDA	$14.15
Ptbv Ratio	9.92
Relative Volume	0.74x
Revenue	5,537,789,000x
SBC By Revenue	1.84x
Share Based Comp	101,641,000
Tax By Revenue	6.93x
Tax Rate	20.16%
Tr20y	931.35%
Tr6m	-17.4%
Us State	California
Volume	993,474
Z Score	12.56

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

RMD dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.2%

$2.40 annual per share

Payout ratio

+23.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+9.0%

14 consecutive years of growth

Total shareholder yield

+1.8%

Next ex-dividend date: 2026-05-14

Performance

RMD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns RMD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+76.1%

Float: +99.4% of shares outstanding

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

RMD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.1

Neutral momentum band

Price vs 200-day MA

-18.7%

50/200-day relationship not available

Beta (5Y)

0.84

Moves roughly with the market

Sharpe ratio

-0.80

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About RMD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current RMD stock rating?

ResMed Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full RMD analysis?

The full report lives at /stocks/RMD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for RMD?

The latest report frames RMD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the RMD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.